Clinical Trial Update: TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis [NA]

View source ↗

Summary

A clinical trial evaluating TheraSpheres for unresectable hepatocellular carcinoma and portal vein thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Portal Vein Thrombosis

Drugs mentioned

• TheraSphere (yttrium-90 glass microspheres)

Snippet

Sponsor: Emory University | Conditions: Liver Cancer, Portal Vein Thrombosis | NA | Status: COMPLETED